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Introduction {#sec1}
============

Among adults older than 50 years, colorectal cancer incidence rates had increased by 22% from 2000 to 2013, which was one of the most common malignancies in the world ([@bib37], [@bib33]). Also, some clinical diagnostic methods for colorectal cancer such as colonoscopy, surgical procedures, and carcinoembryonic antigen are well explored ([@bib16], [@bib52], [@bib53], [@bib44], [@bib1]). However, all these traditional methods still suffer from some inevitable drawbacks, including extensive medical experience needed, low sensitivity, and great pain to patients ([@bib16], [@bib52], [@bib53], [@bib44], [@bib1]). Therefore the development of a non-invasive early diagnostic technique with high sensitivity is urgently demanded for specific visualization of colorectal cancer.

Optical imaging method capable of providing direct visualization of disease with high spatial/temporal resolution and high sensitivity has emerged as an indispensable tool for non-invasive disease diagnosis ([@bib13], [@bib47], [@bib17], [@bib49]). Differing from conventional optical imaging by using the visible and first near-infrared (NIR-I, 700--900 nm) regions, second NIR (NIR-II) optical imaging with emission ranging from 1,000 to 1,700 nm is considered as the next-generation advanced optical imaging technique with superior imaging sensitivity and significant improvement in spatial resolution owing to the remarkably reduced scattering losses ([@bib19], [@bib20], [@bib21], [@bib22], [@bib31], [@bib9], [@bib50]). *In vivo* NIR-II imaging began with the utilization of single-walled carbon nanotubes ([@bib21], [@bib22], [@bib23], [@bib10]); since then, several other probes including small-molecule dyes ([@bib46]), semiconductor quantum dots ([@bib2], [@bib19], [@bib20]), and rare-earth-doped materials ([@bib55], [@bib27], [@bib28], [@bib45]) have been explored for *in vivo* NIR-II imaging. However, most of the developed NIR-II probes presented low specificity for tumor diagnosis, resulting in the absence of targeting visualization of colorectal cancer. Therefore the development of probe with high sensitivity, excellent spatial resolution, and tumor-targeted properties holds great significance for improving the diagnostic sensitivity.

It is well known that colon cancer cells overexpress cystathionine-β-synthase, resulting in larger amounts of H~2~S in tumor than the adjacent normal tissue or non-transformed cells ([@bib36]). Various fluorescent probes for H~2~S intracellular imaging were successfully developed by using the visible and NIR-I region ([@bib30], [@bib48], [@bib40], [@bib41], [@bib38], [@bib42], [@bib34], [@bib52], [@bib53]). However, few probes have been employed for *in vivo* H~2~S-stimulated imaging owing to the limitations of penetration depth and poor spatial resolution by using the traditional visible and NIR-I optical imaging ([@bib30], [@bib48], [@bib40], [@bib41]). Undoubtedly, H~2~S-activated emissions in NIR-II window can provide valuable insight into the accurate and specific diagnosis of colorectal cancers *in vivo*. Nevertheless, *in situ* endogenous H~2~S-activated NIR-II-emissive probes for targeting diagnosis of colon cancer was still scarcely explored. Very recently, a conceptual study was proposed by designing an H~2~S-activated NIR-II optical probe based on the core-shell silica nanocomposites encapsulating an H~2~S-responsive organic molecule for detection of colon cancer *in vivo* ([@bib44]). However, this NIR-II fluorescence imaging probe suffers from some intrinsic problems, such as the complex synthesis process, photo-bleaching, and low photo-stability of organic molecular probes, which impede its further applications in bioimaging fields ([@bib17], [@bib35]). Therefore, developing a new H~2~S-activated inorganic nanoparticulate probe with highly simple synthesis method, non-photo-bleaching nature, high quantum yield (QY), and high photo-stability is highly desirable.

Biomolecule-assisted synthesis ([@bib56], [@bib11], [@bib40], [@bib41], [@bib3], [@bib4], [@bib5], [@bib15]) has been demonstrated to be an excellent and useful method for the preparation of inorganic nanomaterials with good biocompatibility and stability in biomedical applications. For example, bovine serum albumin (BSA), tryptophan-based peptides, and chicken egg white (CEW) have been used to prepare carbon-, noble metal-, and metal-based oxide or sulfide nanomaterials ([@bib7], [@bib39], [@bib43], [@bib3], [@bib4], [@bib32], [@bib54], [@bib25]). Among these biomolecules, the CEW complex consists of multiple proteins and is extremely cheap and easily available in daily life ([@bib56], [@bib11]). Thus, exploring new H~2~S-activatable NIR-II probe via CEW complex is highly desirable for specific colon cancer detection.

Herein, endogenous H~2~S-triggered NIR-II-emitting nanoprobe based on Ag-CEW complex ([Scheme 1](#sch1){ref-type="fig"}) for specific visualization of colorectal cancer was designed via *in situ* chemical reaction between Ag-CEW and overexpressed H~2~S gas in colorectal cancer. The Ag-CEW complex was synthesized by an environment-friendly method by using CEW as the surface ligands for chelating Ag^+^ at room temperature. More importantly, *in situ* H~2~S-activatable NIR-II-emitting nanoprobe for *in vivo* specific diagnosis of colorectal cancer was achieved. *In vivo* histological examination was carried out to evaluate the biotoxicity of the Ag-CEW complex.Scheme 1Schematic Illustration of the Synthesis Procedure of Ag-CEW Complex and Endogenous H~2~S-Triggered *In Situ* Synthesis of Ag~2~S QDs from Ag-CEW Complex for Highly Specific Visualization of Colon Cancer

Results {#sec2}
=======

Preparation and Characterization of the Ag-CEW Complex after Adding S^2−^ {#sec2.1}
-------------------------------------------------------------------------

As a proof of concept, Na~2~S was used to simulate endogenous H~2~S for investigating the *in situ* reaction of Ag-CEW complex with S^2−^. As shown in [Figure 1](#fig1){ref-type="fig"}A, when Ag^+^ (1 mmol) is added into CEW aqueous solution (2 mL), CEW can adsorb Ag^+^ ions and generate Ag-CEW complex. After adding Na~2~S aqueous solution, Ag^+^ embedded in the three-dimensional structures of the CEW proteins could react with S^2−^ at room temperature within 200 ms ([Figure S1](#mmc1){ref-type="supplementary-material"}) to produce Ag~2~S quantum dots (QDs). The shape and size of the CEW-capped Ag~2~S QDs were characterized by transmission electron microscopy (TEM). As demonstrated in [Figure 1](#fig1){ref-type="fig"}B, CEW-capped Ag~2~S QDs present ultrasmall particle structure with size of about 6.5 nm. High-resolution TEM ([Figure 1](#fig1){ref-type="fig"}C) revealed the high crystallization nature of Ag~2~S QDs, and the distance between the lattice fringes was measured to be 2.4 Å, corresponding to the d-spacing of the (013) crystal plane of the monoclinic phase. The crystal phase structure was further detected by X-ray diffraction ([Figure 1](#fig1){ref-type="fig"}D), in which all the diffraction peaks were matched well with the standard monoclinic phase Ag~2~S (JCPDS File No. 14-0072). Furthermore, the elemental compositions of Ag~2~S QDs were investigated by X-ray photoelectron spectroscopy (XPS). As demonstrated in [Figure 1](#fig1){ref-type="fig"}E, the sample is mainly composed of Ag, S, C, O, N, and Na elements. And the XPS peaks at 367.7 and 373.7 eV are related to the Ag 3*d*~5/2~ and 3*d*~3/2~, respectively. In contrast, the S*2*~^p^~ peak at 162.8 eV is ascribed to S in Ag~2~S-CEW QDs ([Figures 1](#fig1){ref-type="fig"}F and 1G), further verifying the formation of Ag~2~S. All these results demonstrated that Ag~2~S QDs were readily achieved by adding Na~2~S via chemical reaction with Ag-CEW complex at room temperature. To prove the capability of CEW coordination with other metallic ions as a general synthesis strategy, Pb-CEW complex was also synthesized by the same method as the Ag-CEW complex. After adding Na~2~S, CEW-capped PbS QDs ([Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}) were also obtained. These findings reveal that our designed biomolecule-assisted synthesis strategy is a general route for ultrafast formation of sulfide-based QDs at room temperature without heating.Figure 1Microstructure and Crystal Phase of the As-Prepared Ag~2~S-CEW QDs(A) Schematic illustration of the Na~2~S-triggered *in situ* chemical reaction with Ag-CEW to form Ag~2~S QDs.(B) TEM image of Ag~2~S-CEW QDs.(C) High-resolution TEM image of Ag~2~S-CEW QDs.(D) The typical XRD pattern of the *in situ*-synthesized Ag~2~S-CEW QDs.(E) XPS spectrum for Ag~2~S-CEW QDs.(F) The corresponding high-resolution XPS spectrum of Ag (3d).(G) The corresponding high-resolution XPS spectrum of S (2P).

NIR-II Optical Characteristics of Ag-CEW Complex {#sec2.2}
------------------------------------------------

Owing to the efficient NIR-II emission of Ag~2~S ([@bib12], [@bib26]), the S^2−^ activated NIR-II emission properties of Ag-CEW complex were then studied. The Ag-CEW complex presents significant optical response to Na~2~S ([Figure 2](#fig2){ref-type="fig"}A). After adding Na~2~S solution, the UV-visible absorption spectrum of the Ag-CEW complex solution showed an increasing absorption in the shorter wavelengths ([Figure S4](#mmc1){ref-type="supplementary-material"}), which was consistent with previously reported Ag~2~S QDs, indicating the formation of Ag~2~S-CEW QDs ([@bib12], [@bib26]). Then the fluorescent emission spectra ([Figure 2](#fig2){ref-type="fig"}B) of Ag~2~S-CEW QDs were detected, demonstrating a strong NIR-II emission peak around 1,090 nm. As demonstrated in [Figure 2](#fig2){ref-type="fig"}B, with increasing the S^2−^ concentration from 0.10 to 0.60 μM, the NIR-II emission intensity is gradually increased, which is also vividly revealed by *in vitro* phantom imaging ([Figure 2](#fig2){ref-type="fig"}C). Also, the QY of the NIR-II emission in the explored Ag~2~S-CEW QDs dispersed in water is measured to be ∼11%, which is higher than that of organic small-molecule probes ([@bib46]). To further reveal the size-dependent NIR-II emission, Ag~2~S-CEW QDs with different sizes by using the same method were synthesized. As demonstrated in [Figure S5](#mmc1){ref-type="supplementary-material"}, with increasing particle size, the NIR-II emitting intensity was dramatically decreased, which was consistent with previous report ([@bib51]).Figure 2NIR-II Luminescence Properties of Ag-CEW after Adding Na~2~S(A) Schematic illustration of S^2−^-triggered NIR-II emission in Ag-CEW solution.(B) S^2−^ concentration-dependent NIR-II emission spectra of Ag-CEW in the presence of Na~2~S under 808 nm laser excitation.(C) *In vitro* NIR-II phantom imaging of Ag-CEW solutions by adding different concentrations of Na~2~S.(D) The NIR-II signal intensity of Ag-CEW solutions treated with different electrolytes and biomolecules, exhibiting highly specific response to S^2−^.(E) The photo-stability curve in serum, blood, phosphate-buffered saline (PBS), and water.(F) *In vitro* phantom NIR-II fluorescent imaging of the Ag~2~S-CEW QDs in different media (serum, blood, PBS, and water) at the same concentration under continuous 808 nm laser illumination.

It is well known that H~2~S plays an important role in colon cancer with concentrations ranging from 0.3 to 3.4 mmol L^−1^ ([@bib36], [@bib18], [@bib8]). Therefore, highly sensitive and specific detection of S^2−^ is required. To demonstrate the detection limit, the quantitative emission intensity ([Figure S6](#mmc1){ref-type="supplementary-material"}) and linear relationship ([Figure S7](#mmc1){ref-type="supplementary-material"}) within concentration ranging from 0.10 to 0.60 μM of S^2−^ were studied, indicating the ultrasensitive detection of S^2−^ with detectable limit of 35 nM, which was more accurate for H~2~S detection than the previously reported fluorescent H~2~S probes ([@bib29]). Therefore the detection limit of Ag-CEW is sufficient for detection of colon cancer *in vivo*. To further reveal the specific detection of S^2−^, various ions and biomolecules were used for NIR-II luminescence response ([Figure 2](#fig2){ref-type="fig"}D). As demonstrated, unlike the notable optical response observed in the presence of S^2−^, no variations in fluorescence intensity were observed upon the addition of the same concentration of other molecules. These findings demonstrate that the Ag-CEW complex can be used as a highly sensitive and specific probe for colon cancer detection owing to the overexpression of H~2~S in tumor site.

As a comparison study, the Ag-BSA complex and AgNO~3~ solutions with same concentration were also used for S^2−^-induced NIR-II emission. As shown in [Figure S8](#mmc1){ref-type="supplementary-material"}, Ag-CEW complex presents higher NIR-II emission intensity than Ag-BSA and AgNO~3~, which is mainly attributed to the small size of Ag~2~S QDs ([Figure S9](#mmc1){ref-type="supplementary-material"}) synthesized by using Ag-CEW complex. Thus the Ag-CEW complex is more beneficial for NIR-II optical bioimaging applications than Ag-BSA and AgNO~3~. Moreover, the photo-stability curve ([Figure 2](#fig2){ref-type="fig"}E) and *in vitro* phantom bioimaging ([Figure 2](#fig2){ref-type="fig"}F) in different buffer solutions reveal that the Ag~2~S-CEW QDs formed by *in situ* reaction present superior photo-stability with a photo-bleaching degree of 0.6% in 60 min, which is relatively lower than the organic molecule dye ([@bib21], [@bib22]).

To further prove the binding stability of Ag and CEW molecules, the leaked amounts of Ag^+^ in Ag-CEW complex and AgNO~3~ were also measured by using a silver assay kit as direct color indicator. As shown in [Figure S10](#mmc1){ref-type="supplementary-material"}, free Ag^+^ at a low concentration of about 0.00--4.60 nM and pH value ranging from 4 to 7 can react with the silver assay kit to change the solution color from transparent to red color. In contrast, the Ag-CEW complex solution presents no obvious color change even at a concentration ranging from 0.46 nM to 4.6 nM, demonstrating the strong chelation of Ag^+^ and CEW and high structure stability of Ag-CEW complex. These results reveal no leakage of Ag^+^ or very limited leakage less than about 0.46 nM from the Ag-CEW complex, which is significantly lower than the safe level of free Ag^+^ of 9.2 nM ([@bib14], [@bib6]).

NIR-II Optical Imaging-Guided Specific Diagnosis of Colorectal Tumor {#sec2.3}
--------------------------------------------------------------------

Before *in vivo* imaging, *in vitro* cell imaging was first performed. The HCT-116 cells were incubated with Ag-CEW complex for 36 h at 37°C. The fluorescent images of cells were recorded by using the homemade NIR-II imaging system under irradiation at 808 nm laser. Compared with the control group ([Figure S11](#mmc1){ref-type="supplementary-material"}A) treated with PBS, a bright NIR-II fluorescence signal ([Figure S11](#mmc1){ref-type="supplementary-material"}B) was observed from HCT-116 cells cultured with Ag-CEW complex, validating the H~2~S (generated from HCT-116 cells)-activated NIR-II emission *in vitro*.

Encouraged by the S^2−^-activated high-performance NIR-II emission of Ag-CEW complex, *in vivo in situ* reaction of Ag-CEW complex with endogenous H~2~S in colon cancer was carried out. For specifically lighting up colon cancer, tumor-bearing (HCT116) mouse was injected with Ag-CEW complex solution and used for *in vivo* NIR-II fluorescence imaging. Owing to the large overexpressed levels of endogenous H~2~S, a significant NIR-II signal ([Figure 3](#fig3){ref-type="fig"}A) was only observed in tumor site and gradually increased by prolonging time. After 5 days of injection, the NIR-II signal reached up to a maximum value, indicating the complete *in situ* chemical reaction between Ag-CEW and endogenous H~2~S to form NIR-II-emitting Ag~2~S QDs. In addition, the signal-to-noise ratio (SNR) between the tumor and normal site was further evaluated to be 32, verifying the highly sensitive optical diagnosis of colon tumor. To further demonstrate the specific recognition of colon cancer, a lung (A549) tumor-bearing model was also used for NIR-II optical imaging. As shown in [Figure 3](#fig3){ref-type="fig"}B, almost no NIR-II signal was observed before injection of Na~2~S (1 μM) in lung cancer. In contrast, with injection of Na~2~S after 7 days, the tumor site also presents a bright NIR-II signal. The corresponding NIR-II average intensity of HCT116/A549 tumor-bearing mice was exhibited in [Figure 3](#fig3){ref-type="fig"}C. The specific and precise location of NIR-II optical signals in colon tumor revealed that the Ag-CEW complex could specifically light up colorectal cancer. Moreover, the inductively coupled plasma mass spectrometry analysis ([Figure S12](#mmc1){ref-type="supplementary-material"}) reveals the presence of Ag and S ions, further demonstrating that the NIR-II emission in tumor tissues originated from *in situ* endogenous H~2~S-activatable Ag~2~S QDs.Figure 3*In Vivo*-Specific Visualization of Colon Cancer Based on *In Situ* Endogenous H~2~S Activation of Ag-CEW Complex(A) Colon (HCT116) tumor-bearing mouse.(B) Lung (A549) tumor-bearing mouse.(C) The mean NIR-II signal intensity change in the tumor region from 1 to 7 days.

It should be noted that most of the developed NIR-II probes presented low specificity for tumor diagnosis and undesired background interference signals from the reticuloendothelial (RES) system, such as the liver and spleen ([@bib19], [@bib20], [@bib24], [@bib45], [@bib28]). Moreover, it is still a great challenge to design an inorganic probe for highly specific tumor diagnosis with eliminated unspecific interference signal from the RES system (liver, spleen). In our designed endogenous H~2~S-activated Ag-CEW system, the unspecific signal from normal RES tissues can be completely eliminated because of the absence of overexpressed H~2~S in these tissues. To reveal this, *ex vivo* imaging ([Figure S13](#mmc1){ref-type="supplementary-material"}) of the isolated organs such as the heart, liver, spleen, lung, and kidney was performed and no NIR-II signals were observed in these organs, validating the successful elimination of the interference signal from the RES system. Therefore, compared with the direct injection of Ag~2~S QDs ([@bib19], [@bib20], [@bib24]), our designed endogenous H~2~S-activated Ag-CEW probes not only present much higher SNR (\>30) but also hold highly specific imaging of colorectal tumor with eliminated unspecific interference signal from the RES system. Therefore the designed Ag-CEW complex can be used as ideal endogenous H~2~S-triggered NIR-II emitting probe for highly specific and sensitive diagnosis of colon cancer.

To detect the pathological changes induced by the Ag-CEW complex, a histological examination of the mouse organs was performed. As shown in [Figure S14](#mmc1){ref-type="supplementary-material"}, no noticeable organ damage was found in the stained tissues after intravenous injection of Ag-CEW from 7 to 30 days, validating the negligible biotoxicity and high biocompatibility of Ag-CEW complex *in vivo*.

Discussion {#sec3}
==========

In summary, we explore an *in situ* endogenous H~2~S-activatable NIR-II-emissive Ag-CEW nanoprobe for intelligently lighting up colorectal cancer. Our designed Ag-CEW complex possesses high photo-stability and NIR-II emission at 1,090 nm. *In vivo* toxicity tests revealed the excellent biocompatibility and negligible side effects of the Ag-CEW complex. Importantly, the Ag-CEW complex was successfully used for NIR-II optical imaging-guided specific diagnosis of colorectal tumor with high sensitivity and completely eliminated interference signal from RES system by *in situ* H~2~S activation. Therefore, it is expected that our designed endogenous H~2~S-triggered NIR-II emitting probe can facilitate the development of specific diagnosis technique for *in vivo* colon cancer detection.

Limitations of Study {#sec3.1}
--------------------

We have designed *in situ* endogenous H~2~S-activatable NIR-II-emissive Ag-CEW nanoprobe for intelligently lighting up colorectal cancer. Cell types of colon cancer, including HT-29 and COLO3, have not been detected and are worth investigating in the future.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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